MDWD — MediWound Ltd. catalysts
Next verified catalyst
2026-12-01 — A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debr · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of Eschar
Phase 3 · Venous Leg Ulcer (VLU) |
MDWD MediWound Ltd. | EscharEx (EX-03) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|